Cargando…
Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease
There is paucity of data on extended dosing interval between two doses of AZD1222 (AstraZeneca) in patients with Autoimmune Rheumatic Diseases (AIRD). We aimed to study the humoral response and rate of breakthrough infections between the two groups who had received the second dose of vaccine at 4 we...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244552/ https://www.ncbi.nlm.nih.gov/pubmed/35760938 http://dx.doi.org/10.1007/s10067-022-06247-3 |